Investigation of antileishmanial activities of Tio2@Ag nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro

Experimental Parasitology

Volumn 135, Issue 1, 2013, Pages 55-63

  Allahverdiyev, Adil M ^a   Abamor, Emrah Sefik ^a   Bagirova, Melahat ^a   Baydar, Serap Yesilkir ^a   Ates, Sezen Canim ^a   Kaya, Figen ^a   Kaya, Cengiz ^a   Rafailovich, Miriam ^b  

^a YILDIZ TECHNICAL UNIVERSITY   (Turkey)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Antileishmanial; Leishmania; Nanoparticles; Parasites

Indexed keywords

SILVER NANOPARTICLE; TITANIUM DIOXIDE; TITANIUM DIOXIDE SILVER NANOPARTICLE; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANTILEISHMANIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG SYNTHESIS; HOST CELL; IN VITRO STUDY; LEISHMANIA INFANTUM; LEISHMANIA TROPICA; LIGHT DARK CYCLE; MACROPHAGE; METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

ANTILEISHMANIAL; LEISHMANIA; NANOPARTICLES; PARASITES;

ANIMALS; DARKNESS; LEISHMANIA INFANTUM; LEISHMANIA TROPICA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; LIGHT; MACROPHAGES; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; SILVER; TITANIUM;

EID: 84880287465     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2013.06.001     Document Type: Article

References (39)

1. Akhavan O. Lasting antibacterial activities of Ag-TiO2/Ag/a-TiO2 nanocomposite thin film photocatalysts under solar light irradiation. J. Colloid Interface Sci. 2009, 336:117-124.
2. Allahverdiyev A.M., Abamor E.S., Bagirova M., Rafailovich M. Antimicrobial effects of TiO(2) and Ag(2)O nanoparticles against drug-resistant bacteria and leishmania parasites. Future Microbiol. 2011, 6:933-940.
3. Allahverdiyev A.M., Abamor E.S., Bagirova M., Ustundag C.B., Kaya C., Kaya F., Rafailovich M. Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light. Int. J. Nanomed. 2011, 6:2705-2714.
4. Alzate J.F., Arias A., Mollinedo F., Rico E., de la Iglesia-Vicente J., Jiménez-Ruiz A. Edelfosine induces an apoptotic process in Leishmania infantum that is regulated by the ectopic expression of Bcl-XL and Hrk. Antimicrob. Agents Chemother. 2008, 52(10):3779-3782.
5. Amato V., Amato J., Nicodemo A., Uip D., Amato-Neto V., Duarte M. Treatment of mucocutaneous leishmaniasis with pentamidine isothionate. Ann. Dermatol. Venereol. 1998, 125:492-495.
6. 2 nanoparticles under solar simulated light. J. Theor. Appl. Phys. 2011, 4.
7. Basu J.M., Mookerjee A., Sen P., Bhaumik S., Sen P., Banerjee S., Naskar K., Choudhuri S.K., Saha B., Raha S., Roy S. Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages. Antimicrob. Agents Chemother. 2006, 50:1788-1797.
8. Brunet L., Lyon D.Y., Hotze E.M., Alvarez P.J., Wiesner M.R. Comparative photoactivity and antibacterial properties of C60 fullerenes and titanium dioxide nanoparticles. Environ. Sci. Technol. 2009, 43:4355-4360.
9. 2) photocatalysts as alternative means for Listeria monocytogenes biofilm disinfection in food processing. Food Microbiol. 2011, 28:164-170.
10. Cornelissen A.W., Schetters T.P. Vaccines against protozoal diseases of veterinary importance. FEMS Immunol. Med. Microbiol. 1996, 15:61-72.
11. Croft S.L., Coombs G.H. Leishmaniasis - current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol. 2003, 19:502-508.
12. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 2004, 27:305-318.
13. 2 surfaces. Antibacterial effect on Pseudomonas aeruginosa. J. Colloid Interface Sci. 2010, 350:402-408.
14. Fricker S.P., Mosi R.M., Cameron B.R., Baird I., Zhu Y., Anastassov V., Cox J., Doyle P.S., Hansell E., Lau G., Langille J., Olsen M., Qin L., Skerlj R., Wong R.S., Santucci Z., McKerrow J.H. Metal compounds for the treatment of parasitic diseases. J. Inorg. Biochem. 2008, 102(10):1839-1845.
15. 2. J. Colloid Interface Sci. 2007, 311:514-522.
16. He C., Yu Y., Hu X.F., Larbot A. Influence of silver doping on the photocatalytic activity of titania films. Appl. Surf. Sci. 2002, 200:239-247.
17. Karunakaran C., Abiramasundari G., Gomathisankar P., Manikandan G., Anandi V. Cu-doped TiO(2) nanoparticles for photocatalytic disinfection of bacteria under visible light. J. Colloid Interface Sci. 2010, 352:68-74.
18. Kedzierski L. Leishmaniasis vaccine: where are we today?. J. Glob. Infect. Dis. 2010, 2:177-185.
19. 2@Ag nanoparticles on silk fiber to produce multifunctional fabrics. J. Colloid Interface Sci. 2011, 358:307-315.
20. 2 nanoparticles on cancer cells. Nanoscale Res. Lett. 2011, 6:356.
21. 2 nanocatalysts for wastewater purification: tapping energy from the sun. Water Sci. Technol. 2006, 54:47-54.
22. Lowe G., Droz A.S., Vilaivan T., Weaver G.W., Tweedale L., Pratt J.M., Rock P., Yardley V., Croft S.L. Cytotoxicity of (2,20:6,20 0-terpyridine) platinum (II) complexes to Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. J. Med. Chem. 1999, 42:999-1006.
23. Minodier P., Parola P. Cutaneous leishmaniasis treatment. Travel Med. Infect. Dis 2007, 5:150-158.
24. Murray H.W., Berman J.D., Davies C.R., Saravia N.G. Advances in leishmaniasis. Lancet 2005, 366:1561-1577.
25. Murray H.W., Nathan C.F. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 1999, 189:741-746.
26. Navarro M., Gabbiani C., Messori L., Gambino D. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives. Drug Discov. Today 2010, 23-24:1070-1078.
27. Natera S., Machuca C., Padron-Nieves M., Romero A., Diaz E., Ponte-Sucre A. Leishmania spp.: proficiency of drug-resistant parasites. Int. J. Antimicrob. Agents 2007, 29:637-642.
28. 2-Ag composite layers against methicillin-resistant Staphylococcus aureus. Acta Biomater. 2009, 5:3573-3580.
29. Nino-Martinez N., Martinez-Castanon G.A., Aragon-Pina A., Martinez-Gutierrez F., Martinez-Mendoza J.R., Ruiz F. Characterization of silver nanoparticles synthesized on titanium dioxide fine particles. Nanotechnology 2008, 19:065711.
30. Panacek A., Kvitek L., Prucek R., Kolar M., Vecerova R., Pizurova N., Sharma V.K., Nevecna T., Zboril R. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J. Phys. Chem. B 2006, 110:16248-16253.
31. Reithinger R., Dujardin J.C. Molecular diagnosis of leishmaniasis: current status and future applications. J. Clin. Microbiol. 2007, 45:21-25.
32. Sharma V.K., Yngard R.A., Lin Y. Silver nanoparticles: green synthesis and their antimicrobial activities. Adv. Colloid Interface Sci. 2009, 145:83-96.
33. Su H.L., Chou C.C., Hung D.J., Lin S.H., Pao I.C., Lin J.H., Huang F.L., Dong R.X., Lin J.J. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials 2009, 30:5979-5987.
34. Sundar S., Chakravarty J. Antimony toxicity. Int. J. Environ. Res. Public Health 2010, 7:4267-4277.
35. Tonui W.K., Titus R.G. Cross-protection against Leishmania donovani but not L. braziliensis caused by vaccination with L. major soluble promastigote exogenous antigens in BALB/c mice. Am. J. Trop. Med. Hyg. 2007, 76:579-584.
36. Tsuang Y.H., Sun J.S., Huang Y.C., Lu C.H., Chang W.H.S., Wang C.C. Studies of photokilling of bacteria using titanium dioxide nanoparticles. Artif. Organs 2008, 32:167-174.
37. Verma N.K., Dey C.S. The anti-leishmanial drug miltefosine causes insulin resistance in skeletal muscle cells in vitro. Diabetologia 2006, 49:1656-1660.
38. Wu T.S., Wang K.X., Li G.D., Sun S.Y., Sun J., Chen J.S. Montmorillonite-supported Ag/TiO(2) nanoparticles: an efficient visible-light bacteria photodegradation material. ACS Appl. Mater. Interfaces 2010, 2:544-550.
39. 2 nanoparticles co-doped with silver and nitrogen for antibacterial application. J. Nanosci. Nanotechnol. 2010, 10:4868-4874.